Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AI Labs Group S.L
Pediatric Brain Tumor Consortium
Duke University
National Institutes of Health Clinical Center (CC)
Stanford University
X4 Pharmaceuticals
The Center for the Biology of Chronic Disease
Kaohsiung Medical University Chung-Ho Memorial Hospital